Supplementary Tables 1 - 7 from Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma
Year: 2023
Type: supplementary-materials
Abstract: Table 1. Tumor Histology, Cellularity, and Chemotherapy Respons. Table 2. Significance and Fold Change of 770 genes and corresponding pathways in pre- and post-NACT. Table 3. List of top canonical pathways, molecular and cellular function, toxicity list, and networks. Table 4. Classification of all variants identified in DNA and cell-free DNA of pre- and post-NACT. Protein Change. Table 5. Number of mutant genes and specific variants in pre- and post-NAC. Table 6. All variants in pre- and post-NACT and recurrent plasma samples.Table 7. Potential FDA-approved targeted therapies and clinical trials based on gene level alterations.
Authors: Rebecca C. Arend, Angelina I. Londoño, Allison M. Montgomery, Haller J. Smith, Zachary C. Dobbin, Ashwini A. Katre, Alba Martinez, Eddy S. Yang, Ronald D. Alvarez, Warner K. Huh, Kerri S. Bevis, J. Michael Straughn, Jacob M. Estes, Lea Novak, David K. Crossman, Sara J. Cooper, Charles N. Landen, Charles A. Leath
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362486905